The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs
Oncotarget (2016) - Comments
pubmed: 27764794  doi: 10.18632/oncotarget.12640  issn: 1949-2553 

Pei Y. Liu, Nicholas Sokolowski, Su T. Guo, Faraz Siddiqi, Bernard Atmadibrata, Thomas J. Telfer, Yuting Sun, Lihong Zhang, Denise Yu, Joshua Mccarroll, Bing Liu, Rui H. Yang, Xiang Y. Guo, Andrew E. Tee, Ken Itoh, Jenny Wang, Maria Kavallaris, Michelle Haber, Murray D. Norris, Belamy B. Cheung